Literature DB >> 31705237

[Primary aldosteronism : Genetics and pathology].

U Scholl1,2.   

Abstract

BACKGROUND: Primary aldosteronism, the excessive production of the steroid hormone aldosterone, is the most common cause of secondary hypertension. Common subforms include bilateral adrenal hyperplasia and aldosterone-producing adenoma.
OBJECTIVES: The goal of this review is to summarize important publications on the genetic basis of primary aldosteronism.
RESULTS: Somatic mutations in the KCNJ5, CACNA1D, ATP1A1, and ATP2B3 genes have been described as causes of aldosterone-producing adenomas. They eventually all lead to increased cellular calcium influx and aldosterone production. The mechanisms of rare CTNNB1 mutations are less defined. Correlations between mutations and different histologic characteristics as well as gender and ethnicity remain unexplained. Recent publications suggest that bilateral hyperplasia is at least partially due to so-called aldosterone-producing cell clusters, often with mutations in CACNA1D. Rare familial forms show mutations in the CYP11B2, CLCN2, KCNJ5, CACNA1H, or CACNA1D genes.
CONCLUSIONS: These results suggest that a significant fraction of primary aldosteronism is due to somatic mutations in single genes.

Entities:  

Keywords:  Aldosterone-producing adenoma; Aldosterone-producing cell clusters; Bilateral adrenal hyperplasia; Idiopathic hyperaldosteronism; Mutations

Mesh:

Substances:

Year:  2019        PMID: 31705237     DOI: 10.1007/s00292-019-00682-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  30 in total

1.  Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.

Authors:  J W CONN
Journal:  J Lab Clin Med       Date:  1955-01

2.  Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.

Authors:  Ryo Taguchi; Masanobu Yamada; Yasuyo Nakajima; Tetsurou Satoh; Koshi Hashimoto; Nobuyuki Shibusawa; Atsushi Ozawa; Shuichi Okada; Nana Rokutanda; Daisuke Takata; Yukio Koibuchi; Jun Horiguchi; Tetsunari Oyama; Izumi Takeyoshi; Masatomo Mori
Journal:  J Clin Endocrinol Metab       Date:  2012-01-25       Impact factor: 5.958

3.  Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Authors:  Kazutaka Nanba; Kei Omata; Celso E Gomez-Sanchez; Constantine A Stratakis; Andrew P Demidowich; Mari Suzuki; Lester D R Thompson; Debbie L Cohen; James M Luther; Lan Gellert; Anand Vaidya; Justine A Barletta; Tobias Else; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

4.  Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice.

Authors:  Silvia Monticone; Jacopo Burrello; Davide Tizzani; Chiara Bertello; Andrea Viola; Fabrizio Buffolo; Luisa Gabetti; Giulio Mengozzi; Tracy A Williams; Franco Rabbia; Franco Veglio; Paolo Mulatero
Journal:  J Am Coll Cardiol       Date:  2017-04-11       Impact factor: 24.094

5.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

6.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

7.  CLCN2 chloride channel mutations in familial hyperaldosteronism type II.

Authors:  Gabriel Stölting; Julia Schewe; Ute I Scholl; Anne Thiel; Hua Tan; Carol Nelson-Williams; Alfred A Vichot; Sheng Chih Jin; Erin Loring; Verena Untiet; Taekyeong Yoo; Jungmin Choi; Shengxin Xu; Aihua Wu; Marieluise Kirchner; Philipp Mertins; Lars C Rump; Ali Mirza Onder; Cory Gamble; Daniel McKenney; Robert W Lash; Deborah P Jones; Gary Chune; Priscila Gagliardi; Murim Choi; Richard Gordon; Michael Stowasser; Christoph Fahlke; Richard P Lifton
Journal:  Nat Genet       Date:  2018-02-05       Impact factor: 38.330

8.  Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.

Authors:  Ute I Scholl; Gabriel Stölting; Carol Nelson-Williams; Alfred A Vichot; Murim Choi; Erin Loring; Manju L Prasad; Gerald Goh; Tobias Carling; C Christofer Juhlin; Ivo Quack; Lars C Rump; Anne Thiel; Marc Lande; Britney G Frazier; Majid Rasoulpour; David L Bowlin; Christine B Sethna; Howard Trachtman; Christoph Fahlke; Richard P Lifton
Journal:  Elife       Date:  2015-04-24       Impact factor: 8.713

9.  Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.

Authors:  Ute I Scholl; Gerald Goh; Gabriel Stölting; Regina Campos de Oliveira; Murim Choi; John D Overton; Annabelle L Fonseca; Reju Korah; Lee F Starker; John W Kunstman; Manju L Prasad; Erum A Hartung; Nelly Mauras; Matthew R Benson; Tammy Brady; Jay R Shapiro; Erin Loring; Carol Nelson-Williams; Steven K Libutti; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Peyman Björklund; Tobias Carling; Christoph Fahlke; Patricia Hidalgo; Richard P Lifton
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330

10.  Activating mutations in CTNNB1 in aldosterone producing adenomas.

Authors:  Tobias Åkerström; Rajani Maharjan; Holger Sven Willenberg; Kenko Cupisti; Julian Ip; Ana Moser; Peter Stålberg; Bruce Robinson; K Alexander Iwen; Henning Dralle; Martin K Walz; Hendrik Lehnert; Stan Sidhu; Celso Gomez-Sanchez; Per Hellman; Peyman Björklund
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.